DUBLIN and CHICAGO, April 28,
2022 /PRNewswire/ -- Providing excellent care
inside and outside of the traditional hospital is the new normal
for patients, clinicians, and payers seeking more choices without
compromising excellent outcomes. Today, Medtronic and GE Healthcare
announce a collaboration focused on the unique needs and demand for
care at Ambulatory Surgery Centers (ASCs) and Office Based Labs
(OBLs). Under this new collaboration, customers can access
extensive product portfolios, financial solutions, and exceptional
service.
The COVID-19 pandemic accelerated the movement of procedures
into the outpatient environment while also driving disease rates
higher, resulting in procedure growth in facilities outside
traditional hospitals, and this growth trend is expected to
continue for years to come.1 Also, since CMS approved
payments for certain cardiovascular procedures in 2020, fixed c-arm
imaging systems have been used more and more frequently in ASCs and
OBLs for cardiac and peripheral vascular
procedures.2
"GE Healthcare Interventional Imaging solutions are built to
help our customers deliver care at a higher level for patients.
With a predicted increase in outpatient cardiology and peripheral
vascular procedures over the coming years, industry leaders like GE
Healthcare need to understand and meet the unique needs of ASCs and
OBLs," said Jim Rapp, vice president
of Interventional Imaging at GE Healthcare. "Our collaboration with
Medtronic is one aspect of our efforts to strengthen efficiency,
workflow, and clinical outcomes for ASCs and OBLs who work with GE
Healthcare."
While patient needs are increasing, there remain high costs and
complexity associated with expanding an existing ASC or building a
new one. GE Healthcare and Medtronic seek to help ASCs navigate
these challenges, bringing the best of each company to deliver
high-quality and cost-effective advanced technology, financial
solutions, and personal service. For GE Healthcare, this includes
consultative planning, construction, a comprehensive suite of
equipment (including imaging, monitoring, and ultrasound), and
exceptional service and digital solutions, including the
Edison-powered AutoRight A.I.-based interventional imaging chain,
which can help clinicians provide the right image at the right dose
automatically for each patient. For Medtronic, this means providing
an extensive portfolio of products for a diverse range of service
lines in the ASC and OBL, from cardiac rhythm to pain management,
peripheral vascular to kyphoplasty. In addition to products,
Medtronic will continue to offer the service that customers have
come to expect from their field experts as well as reimbursement
support, remote solutions, and more.
"As our customers open centers outside of the hospital, they are
looking for support beyond the devices used in medical procedures,"
said Adam King, senior director of
U.S. Enterprise Accounts and Ambulatory Surgery Centers at
Medtronic. "From products and devices to equipment and services, we
provide a full range of technologies and solutions. Our
collaboration with GE Healthcare was formed to better serve the
growth of our ASC and OBL customers with extensive technologies and
dedicated teams who have expertise in outpatient services and can
address all aspects of this evolving sector."
From staff workflow to patient care and more, GE Healthcare and
Medtronic experts and solutions help outpatient health center
owners and clinicians achieve their vision.
About GE Healthcare
GE Healthcare is the $17.7 billion healthcare business of GE (NYSE:
GE). As a leading global medical technology, pharmaceutical
diagnostics and digital solutions innovator, GE Healthcare enables
clinicians to make faster, more informed decisions through
intelligent devices, data analytics, applications and services,
supported by its Edison intelligence platform. With over 100 years
of healthcare industry experience and around 47,000 employees
globally, the company operates at the center of an ecosystem
working toward precision health, digitizing healthcare, helping
drive productivity and improve outcomes for patients, providers,
health systems and researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, Instagram and
Insights for the latest news, or visit our website
www.gehealthcare.com for more information.
About Medtronic
Bold thinking. Bolder actions. We are
Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global
healthcare technology company that boldly attacks the most
challenging health problems facing humanity by searching out and
finding solutions. Our Mission — to alleviate pain, restore health,
and extend life — unites a global team of 90,000+ passionate people
across 150 countries. Our technologies and therapies treat 70
health conditions and include cardiac devices, surgical robotics,
insulin pumps, surgical tools, patient monitoring systems, and
more. Powered by our diverse knowledge, insatiable curiosity, and
desire to help all those who need it, we deliver innovative
technologies that transform the lives of two people every second,
every hour, every day. Expect more from us as we empower
insight-driven care, experiences that put people first, and better
outcomes for our world. In everything we do, we are engineering the
extraordinary. For more information on Medtronic (NYSE: MDT), visit
www.Medtronic.com and follow @Medtronic on Twitter and
LinkedIn.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
1 Sg2 2021 Impact of Change® Forecast: Post-Pandemic
Recovery, Rising Acuity and Ambulatory Shifts. Read more:
https://www.sg2.com/health-care-intelligence-blog/2021/06/sg2-2021-impact-of-change-forecast/
2 The Rise of the Cardiology ASC – Update. Read more:
https://www.ghadvisors.net/research-reports/gha-the-rise-of-the-cardiology-asc/
Contacts:
|
|
|
|
Erika
Winkels
|
Ryan
Weispfenning
|
Medtronic
plc
|
Medtronic
plc
|
Public
Relations
|
Investor
Relations
|
+1-763-526-8478
|
+1-763-505-4626
|
|
|
Emily Davis
|
|
GE
Healthcare
|
|
+1-630-779-0722
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medtronic-and-ge-healthcare-announce-a-collaboration-to-meet-growing-need-for-outpatient-care-301534463.html
SOURCE Medtronic plc